ArticleEFSA journal. European Food Safety Authority2025
Assessment of the feed additives betaine anhydrous (3a920) and betaine hydrochloride (3a925) for all animal species for the renewal of their authorisations (Orffa Additives B.V.).
Article in EFSA journal. European Food Safety Authority, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Assessment of the feed additive consisting of betaine anhydrous (3a920) for all animal species for the renewal of its authorisation (Genencor International B.V.).EFSA journal. European Food Safety Authority · 2026Article
- Assessment of the feed additives betaine anhydrous (3a920) and betaine hydrochloride (3a925) for all animal species for the renewal of their authorisations (Orffa Additives B.V.).EFSA journal. European Food Safety Authority · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of betaine anhydrous and betaine hydrochloride for the renewal of its authorisation. The applicant provided evidence that the additives betaine anhydrous (solid form) and betaine hydrochloride (solid form) both produced by chemical synthesis currently on the market comply with the existing conditions of authorisation. The use of betaine anhydrous and betaine hydrochloride as feed additives in animal nutrition remains safe for target species, consumers and the environment under the current authorised conditions. Regarding user safety, betaine anhydrous and betaine hydrochloride are irritant to skin and eyes. Betaine hydrochloride is also a dermal and respiratory sensitiser. Any exposure to these additives is considered a risk. These conclusions apply, in principle, to any preparations containing the active substances. There is no need for assessing the efficacy of the additives in the context of this renewal of the authorisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.